We have validated the specificity of the WNT10B antibody utilizing transgenic MMTV-Wnt10b-IRES-LacZ-derived tumours and cell lines, human triple negative breast cancer cell lines and Wnt10b-knockout embryos (E.14.5; Supporting Information Fig S1A and B). The gene discussed is WNT10B; the disease is neoplasm.